Singapore well placed for investments in new drugs, says pharma giant MSD 2022-03-27 March 28, 2022 7:06 AM Singapore set to receive its share of investments into the R&D of new drugs, including mRNA-based vaccines and therapies. Source : https://www.straitstimes.com/business/companies-markets/singapore-well-placed-for-investments-in-new-drugs-says-pharma-giant-msd-0 Share FacebookTwitterPinterestWhatsApp Previous articleNew jobs aplenty, but many only offer up to RM2k salariesNext articleUkraine says Russian forces near Chernobyl could pose new radiation threat Latest Articles Sembcorp lifts interim dividend to 11 cents on stronger second-half outlook 2026-08-12 South Korea’s SK Shipping, H-Line swap tankers to create LNG giant 2026-08-12 Singtel Q1 profit falls 71% in absence of Airtel stake sale, sees weaker Singapore business 2026-08-12 CDL triples first-half profit to $300m on strong residential property performance 2026-08-12 DeepSeek publicizes efforts to challenge Anthropic’s Claude code 2026-08-12 S&P 500 ends higher as CoreWeave results fuel AI optimism 2026-08-12